Answers are grounded in this paper and cite their sources.
Case study evaluates biological parameter changes under immunoglobulin treatment in a cat with FIP, suggesting potential therapeutic insights.
Feline infectious peritonitisis a disease determined by a coronavirus, affectingdomestic and wild cats and once triggered is fatal in almost 100%. The occurrence of the related pathology are yet to be fully determined; currently, a certain and confident in-clinicaldiagnosis is unavailable, as is the case for an efficient vaccine or a treatment that will restore to health. These make the feline infectious peritonitis a subject currently undergoing intensive research studies. The paper presents the case of a 5 months cat patient manifesting the rapid evolution effusive form of the disease. The aim of study was to evaluate if the variation of the 24 biological parameters studied was significant under treatment with immunoglobulins of avian origin. The patient tolerated well the supportive therapy based on egg yolk Immunoglobulin Y, without evidences of side effects.
No takes yet. Share an insight, caveat, or question.
Supeanu et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: